APA

Edmonson J. H., McCormack G. W., Fleming T. R., Cullinan S. A., Krook J. E., Malkasian G. D., Podratz K. C., Mailliard J. A., Jefferies J. A. & Barlow J. F. (19860418). Comparison of cyclophosphamide plus cisplatin versus hexamethylmelamine, cyclophosphamide, doxorubicin, and cisplatin in combination as initial chemotherapy for stage III and IV ovarian carcinomas. : Cancer treatment reports.

Chicago

Edmonson J H, McCormack G W, Fleming T R, Cullinan S A, Krook J E, Malkasian G D, Podratz K C, Mailliard J A, Jefferies J A and Barlow J F. 19860418. Comparison of cyclophosphamide plus cisplatin versus hexamethylmelamine, cyclophosphamide, doxorubicin, and cisplatin in combination as initial chemotherapy for stage III and IV ovarian carcinomas. : Cancer treatment reports.

Harvard

Edmonson J. H., McCormack G. W., Fleming T. R., Cullinan S. A., Krook J. E., Malkasian G. D., Podratz K. C., Mailliard J. A., Jefferies J. A. and Barlow J. F. (19860418). Comparison of cyclophosphamide plus cisplatin versus hexamethylmelamine, cyclophosphamide, doxorubicin, and cisplatin in combination as initial chemotherapy for stage III and IV ovarian carcinomas. : Cancer treatment reports.

MLA

Edmonson J H, McCormack G W, Fleming T R, Cullinan S A, Krook J E, Malkasian G D, Podratz K C, Mailliard J A, Jefferies J A and Barlow J F. Comparison of cyclophosphamide plus cisplatin versus hexamethylmelamine, cyclophosphamide, doxorubicin, and cisplatin in combination as initial chemotherapy for stage III and IV ovarian carcinomas. : Cancer treatment reports. 19860418.